Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is a type of hair loss that can lead to complete baldness, often associated with other autoimmune conditions, and half of the cases may see hair return within a year.

One minoxidil-sensitive potassium channel exists in human hair follicles.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Minoxidil and finasteride are effective for male hair loss, minoxidil for female hair loss, and various treatments like corticosteroids work for alopecia areata; treatment should be tailored to the individual.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Early onset and pustules indicate severe hair follicle inflammation, and while antibiotics help, the condition often worsens after treatment stops.

Melanocyte development from neural crest cells is complex and influenced by many factors, and better understanding could help treat skin disorders.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Chemotherapy and bone marrow transplant can cause permanent hair loss.

The article explains the genetic causes and symptoms of various hair disorders and highlights the need for more research to find treatments.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Finasteride and minoxidil work best together for hair loss.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

The cosmetic industry should adapt to the varied beauty standards of ethnic groups and offer specialized treatments.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Hair loss treatments include medications and new methods like low-level light therapy, which may work by boosting cell activity and blood flow.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Thyroid hormone affects skin health, with too little causing rough, pale skin and too much leading to smooth, thin skin, and may also impact wound healing and skin conditions.

Trichoscopy is good for diagnosing and monitoring hair and scalp problems in children but needs more research for certain conditions.

Current treatments for male pattern baldness include minoxidil and finasteride, with new options being developed.

Injectables can feminize or masculinize a transgender person's face, but more research is needed for best practices.

Pseudopelade of Brocq is a unique hair loss condition, but its cause and development are still not fully understood.

Oestrogen and thyrotropin-releasing hormone affect prolactin and its receptor in human skin and hair, suggesting new treatment options for related conditions.